HEALTH

Tiny Organisms and Their Big Role in Fighting Cancer

Tue Jul 08 2025

The world of tiny organisms, or microbes, is having a big impact on cancer. These microbes live in and on our bodies, and they can change how our immune system fights cancer.

The Tumor Microenvironment

The area around a tumor, called the tumor microenvironment, is a busy place. It's full of:

  • Cancer cells
  • Immune cells
  • Other substances that can either help or hurt the tumor.

How Microbes Interact with Cancer

Some microbes can make our immune system attack cancer cells. This can happen through something called immunogenic cell death, where cancer cells die in a way that triggers an immune response. But not all microbes are helpful. Some can cause problems, like:

  • Chronic inflammation
  • Immune suppression, which can make cancer worse.

There are three main ways microbes interact with cancer:

  1. Causing Cancer Directly

    • Examples: Epstein-Barr virus and HPV.
  2. Making It Easier for Infections to Happen

    • Example: When a tumor blocks the respiratory or digestive systems.
  3. Growing in Places Where Microbes Naturally Live

    • Example: The gastrointestinal tract.

Microbes in Cancer Diagnosis and Treatment

Microbes can also help doctors find and treat cancer. They can:

  • Act as markers for cancer, helping doctors diagnose it earlier.
  • Be used to create personalized treatments, making cancer therapy more effective.

The Future of Microbes in Cancer Research

But there's still a lot we don't know. Scientists are working to understand how microbes can be used to:

  • Improve cancer treatments.
  • Understand how changes in the microbiome can affect the effectiveness of immunotherapies.

This research is important for developing new treatments and making existing ones work better.

questions

    Could the pharmaceutical industry be suppressing research on microbiome-mediated cancer treatments to protect their profits?
    How do different microbial communities in the TME vary across different types of cancer?
    Is the focus on microbiome research a distraction from more effective, but less profitable, cancer treatments?

actions